Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-related myopathies

J Zuckner1

  • 1St. Louis University School of Medicine, Missouri.

Rheumatic Diseases Clinics of North America
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Drug-induced myopathies are often misdiagnosed, leading to improper care. Recognizing these often-overlooked conditions is crucial for accurate diagnosis and effective treatment of muscle disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rheumatologic complications of vitamin A and retinoids.

Seminars in arthritis and rheumatism·1995
Same author

Rheumatoid arthritis in the elderly.

Journal of the American Geriatrics Society·1991
Same author

Drug-induced myopathies.

Seminars in arthritis and rheumatism·1990
Same author

Heart disease in systemic sclerosis.

Seminars in arthritis and rheumatism·1989
Same author

Hidden 19S IgM rheumatoid factors.

Seminars in arthritis and rheumatism·1988
Same author

19S IgM rheumatoid factor-7S IgG rheumatoid factor immune complexes isolated in patients with rheumatoid arthritis.

The Journal of laboratory and clinical medicine·1986

Area of Science:

  • Neurology
  • Toxicology
  • Pharmacology

Background:

  • Drug-induced myopathies are a significant clinical concern.
  • These conditions are frequently misdiagnosed and confused with other myopathies.
  • Causes include inflammatory myopathies, toxic agents, metabolic/endocrine issues, genetic factors, malignancies, and infections.

Purpose of the Study:

  • To emphasize the importance of identifying drug-induced myopathies.
  • To highlight the diagnostic challenges and potential for misdiagnosis.
  • To advocate for increased clinical awareness of iatrogenic myopathies.

Main Methods:

  • Review of clinical literature on drug-induced myopathies.
  • Analysis of differential diagnoses for myopathic conditions.

Related Experiment Videos

  • Case study examples (if applicable, not explicitly stated in abstract).

    • Main Results:

    • Drug-induced myopathies are often overlooked in clinical practice.
    • Misdiagnosis stems from confusion with other myopathy types.
    • Delayed or incorrect diagnosis impacts patient care and outcomes.

    Conclusions:

    • Special emphasis on drug-induced myopathy is warranted.
    • Increased physician awareness can prevent misdiagnosis and improve patient management.
    • Further research may elucidate specific drug mechanisms and diagnostic criteria.